Protective efficacy of hepatitis E virus DNA vaccine administered by gene gun in the cynomolgus macaque model of infection

被引:46
作者
Kamili, S [1 ]
Spelbring, J [1 ]
Carson, D [1 ]
Krawczynski, K [1 ]
机构
[1] Ctr Dis Control & Prevent, Div Viral Hepatitis, Natl Ctr Infect Dis, Atlanta, GA 30084 USA
关键词
D O I
10.1086/380801
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The protective efficacy of a DNA vaccine against hepatitis E virus (HEV) infection was tested in cynomolgus macaques (cynos) vaccinated with a plasmid containing a full-length HEV open-reading frame 2 (ORF2) sequence (Burmese strain) and subsequently challenged with a heterologous strain of HEV (Mexican strain). Cynos administered vaccine by gene gun developed antibodies to HEV (anti-HEV), whereas cynos administered vaccine by intradermal injections and cynos administered a mock DNA construct did not develop anti-HEV. Anti-HEV-positive cynos were protected from HEV infection after challenge with an inoculum that produced infection in the anti-HEV-negative cynos. These results indicate that DNA vaccine with HEV ORF2 administered by gene gun is protective against a heterologous viral challenge.
引用
收藏
页码:258 / 264
页数:7
相关论文
共 41 条
[1]   Experimental studies on subclinical hepatitis E virus infection in cynomolgus macaques [J].
Aggarwal, R ;
Kamili, S ;
Spelbring, J ;
Krawczynski, K .
JOURNAL OF INFECTIOUS DISEASES, 2001, 184 (11) :1380-1385
[2]   CROSS-CHALLENGE STUDIES IN RHESUS-MONKEYS EMPLOYING DIFFERENT INDIAN ISOLATES OF HEPATITIS-E VIRUS [J].
ARANKALLE, VA ;
CHADHA, MS ;
CHOBE, LP ;
NAIR, R ;
BANERJEE, K .
JOURNAL OF MEDICAL VIROLOGY, 1995, 46 (04) :358-363
[3]   Long-term serological follow up and cross-challenge studies in rhesus monkeys experimentally infected with hepatitis E virus [J].
Arankalle, VA ;
Chadha, MS ;
Chobe, LP .
JOURNAL OF HEPATOLOGY, 1999, 30 (02) :199-204
[4]   Gene gun mediated vaccination is superior to manual delivery for immunisation with DNA vaccines expressing protective antigens from Yersinia pestis or Venezuelan Equine Encephalitis virus [J].
Bennett, AM ;
Phillpotts, RJ ;
Perkins, SD ;
Jacobs, SC ;
Williamson, ED .
VACCINE, 1999, 18 (7-8) :588-596
[5]   Protection of chimpanzees from high-dose heterologous HIV-1 challenge by DNA vaccination [J].
Boyer, JD ;
Ugen, KE ;
Wang, B ;
Agadjanyan, M ;
Gilbert, L ;
Bagarazzi, ML ;
Chattergoon, M ;
Frost, P ;
Javadian, A ;
Williams, WV ;
Refaeli, Y ;
Ciccarelli, RB ;
McCallus, D ;
Coney, L ;
Weiner, DB .
NATURE MEDICINE, 1997, 3 (05) :526-532
[6]   Enhancement of cellular immune response in HIV-1 seropositive individuals: A DNA-based trial [J].
Boyer, JD ;
Chattergoon, MA ;
Ugen, KE ;
Shah, A ;
Bennett, M ;
Cohen, A ;
Nyland, S ;
Lacy, KE ;
Bagarazzi, ML ;
Higgins, TJ ;
Baine, Y ;
Ciccarelli, RB ;
Ginsberg, RS ;
MacGregor, RR ;
Weiner, DB .
CLINICAL IMMUNOLOGY, 1999, 90 (01) :100-107
[7]   DNA-based immunization by in vivo transfection of dendritic cells [J].
Condon, C ;
Watkins, SC ;
Celluzzi, CM ;
Thompson, K ;
Falo, LD .
NATURE MEDICINE, 1996, 2 (10) :1122-1128
[8]   UPDATE ON THE NEUTRALIZATION OF ANIMAL VIRUSES [J].
DIMMOCK, NJ .
REVIEWS IN MEDICAL VIROLOGY, 1995, 5 (03) :165-179
[9]   Recombinant vaccines for hepatitis E [J].
Emerson, SU ;
Purcell, RH .
TRENDS IN MOLECULAR MEDICINE, 2001, 7 (10) :462-466
[10]  
Feltquate DM, 1997, J IMMUNOL, V158, P2278